KNSA - Kiniksa Pharmaceuticals, Ltd. Qarzning balans kapitallashuviga nisbati
Kiniksa Pharmaceuticals (KNSA) maxsus dori vositalarining mustaqil sikliga tayanadi, bunda perikarditga qarshi davolash vositalarining savdosi tashqi inqirozlardan mustaqil daromadni ta'minlaydi. Kompaniya o'z mavqeini himoya qilish uchun patentlardan foydalangan holda, kam uchraydigan immun tizimi buzilishlarini davolash uchun noyob mahsulotlar yaratadi. Ishlab chiqarish va sinovlarni uchinchi tomon pudratchilariga autsorsing qilish kompaniyaga innovatsiyalarga e'tibor qaratish imkonini beradi va 0.01 darajasidagi aktivning bozor qiymati dinamikasi quyida tasvirlangan.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_KNSA_-_Kiniksa-Pharmaceuticals_-_Debt-to-Net-Assets-Ratio "Kiniksa Pharmaceuticals - KNSA Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Kiniksa Pharmaceuticals, Ltd. (KNSA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Kiniksa Pharmaceuticals|KNSA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Kiniksa Pharmaceuticals Ltd|KNSA - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Kiniksa Corp|KNSA - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi Kiniksa
Kompaniyaning jamlanma tahliliyoti:Kiniksa Pharmaceuticals (KNSA)
Maxsus immunologiya bozoriga tayanadigan Kiniksa Pharmaceuticals (KNSA) biofarmatsevtika biznesi uchun qarzning kapital kitob qiymatiga nisbati tarixi qarz kapitali va o'z mablag'lari o'rtasidagi muvozanatni aks ettiradi. Ushbu ko'rsatkich umumiy majburiyatlarni kapitalning kitob qiymati bilan solishtiradi, bu esa investorlarga avtoimmun kasalliklar uchun terapiyalarni kengaytirayotganda moliyaviy leveraj darajasini va moliyalashtirish tuzilmasining barqarorligini baholash imkonini beradi.
Kiniksa Pharmaceuticals kimlar bilan raqobatlashadi
Balans kapitallashuviga qarzlar ARGX (argenx SE)|biontech.de - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABIVAX (ABVX)|ADMA: Qarzning sof aktivlarga nisbati|PTGX (Protagonist Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Immunovant Therapeutics (IMVT) - Qarzning balans qiymatiga nisbati|GRFS (Grifols, S.A.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar adaptivebiotech.com (ADPT)|Celldex Therapeutics, Inc. (CLDX) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Aurinia Pharmaceuticals Inc (AUPH)|Balans kapitallashuviga qarzlar BCRX|Vera Corp - Sof aktivlarga qarzlar|DNTH: Qarzning balans kapitallashuviga nisbati|PHVS: Qarzning balans qiymatiga nisbati|ABCL (AbCellera Corp) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Tourmaline Bio Inc|PGEN (Intrexon) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PHAR|Qarzning balans kapitallashuviga nisbati Nektar Therapeutics NKTR|Qarzning balans qiymatiga nisbati upstreambio.com (UPB)|ZBIO: Balans kapitallashuviga qarzlar|Immunome Inc - Balans qiymatiga qarzlar|Gossamer Corp - Qarzning balans kapitallashuviga nisbati|KALV - Balans kapitallashuviga qarzlar|Septerna Inc - Balans kapitallashuviga qarzlar|PVLA (pieris.com) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Savara (SVRA)|Qarzning balans qiymatiga nisbati Rigel Pharma|ANAB (AnaptysBio Corp) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar ATXS (Astria Corp)|Qarzning balans kapitallashuviga nisbati ENGN (enGene Holdings Inc.)|RAPT Therapeutics Inc. - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati JBIO (Aerovate)|ACRS - Sof aktivlarga qarzlar|KYTX: Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Tiziana Life Sciences, Ltd.|CABA - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati VTYX|THTX - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Avalo Therapeutics, Inc. (AVTX)|Balans kapitallashuviga qarzlar Eledon|Qarzning sof aktivlarga nisbati Agenus, Inc AGEN|Climb Bio Inc - Balans kapitallashuviga qarzlar|ZURA: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati aTyr Pharma ATYR|ADAG (Adagene Inc.) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati IMA|Qarzning balans qiymatiga nisbati Shattuck Therapeutics|Balans kapitallashuviga qarzlar EQ|Balans kapitallashuviga qarzlar connectbiopharm.com (CNTB)|Immunic - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Atara Biotherapeutics, Inc. ATRA|IFRX (InflaRx GmbH) - Balans kapitallashuviga qarzlar|X4 Pharmaceuticals, Inc (XFOR) - Balans qiymatiga qarzlar|ACET: Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Celularity|INmune Bio (INMB) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati Barinthus Biotherapeutics PLC|KZR (Kezar Life Sciences, Inc) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar SAB Biotherapeutics Inc (SABS)|Akari Therapeutics - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Enlivex Therapeutics Ltd ENLV|Q32 Bio Corp - Balans kapitallashuviga qarzlar|GOVX: Balans kapitallashuviga qarzlar|Edesa (EDSA) - Qarzning balans kapitallashuviga nisbati|IBIO (iBio Corporation) - Qarzning balans kapitallashuviga nisbati|CARM: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar XTLB|Qarzning balans kapitallashuviga nisbati BOLT|Balans kapitallashuviga qarzlar HCWB (hcwbiologics.com)|APVO - Qarzning balans kapitallashuviga nisbati|AIM ImmunoTech, Inc. - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati ADTX (Aditxt Corp)|GRI - Sof aktivlarga qarzlar|XRTX: Balans kapitallashuviga qarzlar|HIND (Vyome Holdings Inc.) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Revelation Bio REVB|Qarzlarning balans kapitallashuviga nisbati Indaptus Corp|Scinai Immunotherapeutics (SCNI) - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati calcimedica.com (CALI)|Balans kapitallashuviga qarzlar AFMD (Affimed N.V.)|Allakos Inc - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati HOOKIPA (HOOK)|IGMS: Qarzning sof aktivlarga nisbati|ITOS (iTeos Therapeutics) - Qarzning balans kapitallashuviga nisbati|oceanbiomedical.com (OCEA) - Qarzning balans qiymatiga nisbati|TCBP (TC BioPharm) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Third Harmonic Bio Inc. (THRD)